Lapiplasty System
Device Y
General payments
$11,669,821
Research payments
$1,034,883
Through program year 2022, $11,669,821 in general payments and $1,034,883 in research payments were reported against Lapiplasty System (Y).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $309 | 2 |
| 2021 | General | $6,034,925 | 5,155 |
| 2021 | Research | $456,202 | 253 |
| 2020 | General | $3,194,496 | 2,138 |
| 2020 | Research | $341,557 | 231 |
| 2019 | General | $2,440,090 | 2,234 |
| 2019 | Research | $237,124 | 135 |
Breakdown
Each share is of general payments naming this product in 2022.
Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2022 where a state was reported.
Records
9,529 general · 619 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.